NCT01717534|Completed
Children Immune Functions
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Heat-treated Lactobacilli on Infections and Immune Status in Healthy Children
Loading search results
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Heat-treated Lactobacilli on Infections and Immune Status in Healthy Children
Sponsor study identifier
interventional
374
1 country
2
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2013
Actual (reported)Study Completion
July 2013
Actual (reported)The purpose of the planned study is to investigate the effect of heat-treated lactobacilli on diarrhea outcome in healthy children 1-4 years old in a randomized, double-blind, placebo-controlled study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2013
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
October 24, 2012
Actual (reported)October 30, 2012
Actual (reported)July 2013
Actual (reported)July 2013
Actual (reported)Days with diarrhea
during 5 months of study period
Number of episodes of upper respiratory infections
during 5 months
Duration of upper respiratory infections
during 5 months
Severity of upper respiratory infections
during 5 months
Severity of gastrointestinal infections
during 5 months
One sachets (1 gram of content) will be consumed once a day, and will be suspended in a provided milk powder to be reconstituted with water. The duration of the treatment is 5 months.
One sachets (1 gram of content) will be consumed once a day, and will be suspended in a provided milk powder to be reconstituted with water. The duration of the treatment is 5 months.
Daily supplement of sachet with 1 g of powder over a 5 months period.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Clinical Research Institute
Tlalnepantla, Edo. de Méx, 54055, Mexico
Centro de Estudios Clinicos de Queretaro S.c.
Querétaro City, Querétaro, 76000, Mexico
Angeles Nava Hernández, MD
Center of Clinical Research of Querétaro
Carlos A. Mena Cedillos, MD
Clinical Research Institute
374 participants (actual enrollment reported by the registry).
First Submitted
October 24, 2012
First Posted
October 30, 2012
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Evaluation of Safe-Water Programs in Baja California Sur, Mexico
Contact the study team to confirm eligibility.
Primary Completion
July 2013
Actual (reported)Study Completion
July 2013
Actual (reported)Last Updated
August 27, 2013
Record last verified: 2013-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: